Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Pulse Biosciences, Inc. (PLSE)
USD26.10
+0.64 (+2.49%)
US NASDAQ Healthcare Medical - Instruments & Supplies
Address
3957 Point Eden Way 94545
Miami, CA, US
Miami, CA, US
CEO
Paul Arthur LaViolette
Website
pulsebiosciences.com
IPO
2016-05-18
CIK 1625101 ISIN US74587B1017
Description
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD26.10
+0.64 (+2.49%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
341.1K
Beta
1.65
Float Shares
12.59M
Free Float %
18.5%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +22.12% | +20.23% | +24.80% | -0.43% | +55.33% | +69.70% | +38.77% | +188.01% | +22.44% | +458.75% | +458.75% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (4 ratings, all time)
Buy
Price Targets & DCF
Current price
26.10
Low
30.00
+15.0%
Consensus
30.00
+15.0%
Median
30.00
+15.0%
High
30.00
+15.0%
DCF (Unlevered)
1.06
-95.9%
DCF (Levered)
1.08
-95.9%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 2 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | 1 |
30.00
+15.0%
|
| Last Year | 3 |
28.33
+8.6%
|
| All Time | 3 |
28.33
+8.6%
|
Quality scores
Altman Z-Score
40.60
Safe zone
Piotroski F-Score
3 / 9
Average
MOAT Score
0 / 10
No MOAT
Composite Rating
C-
Overall Score
1 / 5
Low
DCF Score
2 / 5
Medium
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Instruments & Supplies: +7.9%—
-
EPS growth Medical - Instruments & Supplies: +16.3%-17.4% Q1'26: -4.0% (vs Q1'25)
-
FCF margin FCF growth · Medical - Instruments & Supplies: +27.1%-22,013.4% Q1'26: -3,705.7% (vs Q1'25)
-
EBIT margin Medical - Instruments & Supplies: +13.5%-20,794.6% Q1'26: -4,633.7% (vs Q1'25)
-
ROIC Medical - Instruments & Supplies: +6.0%-976.8% Q1'26: -1,447.7% (vs Q1'25)
-
Share dilution Medical - Instruments & Supplies: +0.1%+15.4% Q1'26: +1.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Instruments & Supplies: -0.24×-0.11× Q1'26: -0.10× (vs Q1'25)
Valuation Multiples
From
To
Consensus Estimates
| Metric |
Dec 2021 actual |
Dec 2022 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 1 EPS Ana. |
Dec 2027 2 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
Dec 2030 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
1.42M
est: 1.45M (-1.9%)
|
700.0K
est: 709.0K (-1.3%)
|
—
est: 800.0K (-100.0%)
|
350.0K
est: 150.0K (+133.3%)
|
3.15M
2.44M – 3.85M
+2,000.0% YoY
|
12.50M
11.00M – 14.00M
+296.8% YoY
|
41.00M
35.54M – 46.45M
+228.0% YoY
|
93.80M
81.30M – 106.27M
+128.8% YoY
|
177.50M
153.85M – 201.09M
+89.2% YoY
|
| EBITDA |
-61.87M
est: 289.2K (-21,492.9%)
|
-56.70M
est: 141.8K (-40,087.6%)
|
-55.08M
est: -160.0K (-34,324.6%)
|
-71.71M
est: -30.0K (-238,941.3%)
|
-630.0K
-770.4K – -487.6K
-2,000.1% YoY
|
-2.50M
-2.80M – -2.20M
-296.8% YoY
|
-8.20M
-9.29M – -7.11M
-228.0% YoY
|
-18.76M
-21.25M – -16.26M
-128.8% YoY
|
-35.50M
-40.22M – -30.77M
-89.2% YoY
|
| EBIT |
-63.01M
est: 289.2K (-21,889.1%)
|
-58.06M
est: 141.8K (-41,043.2%)
|
-56.26M
est: -160.0K (-35,060.8%)
|
-72.78M
est: -30.0K (-242,511.4%)
|
-630.0K
-770.4K – -487.6K
-2,000.1% YoY
|
-2.50M
-2.80M – -2.20M
-296.8% YoY
|
-8.20M
-9.29M – -7.11M
-228.0% YoY
|
-18.76M
-21.25M – -16.26M
-128.8% YoY
|
-35.50M
-40.22M – -30.77M
-89.2% YoY
|
| Net Income |
-63.66M
est: -132.56M (+52.0%)
|
-58.51M
est: -102.20M (+42.8%)
|
-53.59M
est: -64.03M (+16.3%)
|
-72.78M
est: -74.57M (+2.4%)
|
-85.08M
-86.94M – -61.30M
-14.1% YoY
|
-77.49M
-90.90M – -64.08M
+8.9% YoY
|
-49.19M
-57.70M – -40.68M
+36.5% YoY
|
-20.89M
-24.50M – -17.27M
+57.5% YoY
|
26.28M
21.73M – 30.83M
+225.8% YoY
|
| SGA |
33.82M
est: 18.50M (+82.9%)
|
25.97M
est: 9.07M (+186.4%)
|
23.92M
est: 24.72M (-3.2%)
|
32.03M
est: 4.63M (+591.2%)
|
97.32M
75.32M – 119.01M
+2,000.0% YoY
|
386.18M
339.84M – 432.52M
+296.8% YoY
|
1.27B
1.10B – 1.43B
+228.0% YoY
|
2.90B
2.51B – 3.28B
+128.8% YoY
|
5.48B
4.75B – 6.21B
+89.2% YoY
|
| EPS |
-2.28
est: -2.27 (-0.4%)
|
-1.72
est: -1.75 (+1.7%)
|
-0.92
est: -0.95 (+3.2%)
|
-1.08
est: -1.03 (-5.4%)
|
-1.10
-1.29 – -0.91
-7.3% YoY
|
-1.15
-1.35 – -0.95
-4.5% YoY
|
-0.73
-0.86 – -0.60
+36.5% YoY
|
-0.31
-0.36 – -0.26
+57.5% YoY
|
0.39
0.32 – 0.46
+225.8% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-08 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-07 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-06 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-05 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-04 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-01 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-30 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-29 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-28 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-27 | C- | 1/5 | 2/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-24 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-23 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-22 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-21 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-20 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-17 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-04-16 | C- | 1/5 | 3/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-49.54M
OE per share TTM
-0.74
Owner's Yield
-3.14%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
2,635.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
19
Total invested
7.96M
Insider transactions (90d)
0
Beneficial owners (>5%)
4
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ROBERT W. DUGGAN | 2.17M | 15.40% | 2.17M | — | 2.17M | 10.00 | IN | U.S.A | 2017-02-21 | ↗ |
| 2 | Peter A. Appel | 1.23M | 9.75% | 1.23M | — | 1.23M | — | IN | United States | 2016-06-01 | ↗ |
| 3 | Christopher Marlett | 714.3K | 5.70% | — | — | — | — | IN | United States | 2016-06-01 | ↗ |
| 4 | Mark E. Strome | 440.1K | 2.70% | — | — | — | — | IN | United States of America | 2018-05-01 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
19
-62 vs prev Q
New positions
6
Closed positions
67
Increased
8
Reduced
5
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | — | 28.2K +28.2K (+100.0%) | 386.58M +386.6M (+100.0%) | 0.04% +0.042 pp | 0.23% +0.231 pp | USD13.73 +0.0% | 1 qtrs NEW |
| 2 | BLACKROCK, INC. | 1.36M +49.1K (+3.8%) | 18.63M -4.5M (-19.5%) | 2.01% +0.070 pp | 0.00% 0.000 pp | USD17.40 -21.1% | 6 qtrs — |
| 3 | VANGUARD GROUP INC | 1.12M +5.1K (+0.5%) | 15.36M -4.4M (-22.1%) | 1.66% +0.005 pp | 0.00% 0.000 pp | USD13.85 -0.9% | 37 qtrs — |
| 4 | BANK OF AMERICA CORP /DE/ | 800.2K -4.8K (-0.6%) | 10.99M -3.3M (-22.9%) | 1.19% -0.009 pp | 0.00% 0.000 pp | USD19.98 -31.3% | 38 qtrs — |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 464.6K -4.9K (-1.0%) | 6.38M -1.9M (-23.2%) | 0.69% -0.008 pp | 0.00% 0.000 pp | USD10.90 +26.0% | 38 qtrs — |
| 6 | STATE STREET CORP | 447.1K +25.2K (+6.0%) | 6.14M -1.3M (-17.8%) | 0.66% +0.036 pp | 0.00% 0.000 pp | USD11.43 +20.1% | 35 qtrs — |
| 7 | PORTOLAN CAPITAL MANAGEMENT, LLC | 393.5K +291.3K (+285.0%) | 5.40M +3.6M (+198.7%) | 0.58% +0.432 pp | 0.29% +0.192 pp | USD14.76 -7.0% | 2 qtrs — |
| 8 | GRIFFIN ASSET MANAGEMENT, INC. | 226.3K -1.0K (-0.4%) | 3.11M -916.2K (-22.8%) | 0.34% -0.002 pp | 0.34% -0.116 pp | USD6.96 +97.3% | 28 qtrs — |
| 9 | NORTHERN TRUST CORP | 184.3K -8.4K (-4.3%) | 2.53M -879.4K (-25.8%) | 0.27% -0.013 pp | 0.00% 0.000 pp | USD12.65 +8.5% | 36 qtrs — |
| 10 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 152.4K -238.0 (-0.2%) | 2.09M -609.3K (-22.6%) | 0.23% -0.001 pp | 0.00% 0.000 pp | USD14.32 -4.1% | 11 qtrs — |
| 11 | SKOPOS LABS, INC. | 130.3K +100.1K (+330.7%) | 1.84M +1.3M (+244.4%) | 0.19% +0.148 pp | 0.09% +0.027 pp | USD14.64 -6.2% | 4 qtrs — |
| 12 | UBS GROUP AG | 75.9K -947.0 (-1.2%) | 1.04M -318.1K (-23.4%) | 0.11% -0.002 pp | 0.00% +0.000 pp | USD16.59 -17.2% | 11 qtrs — |
| 13 | WESTSIDE INVESTMENT MANAGEMENT, INC. | 66.3K +1.9K (+2.9%) | 910.7K -229.9K (-20.2%) | 0.10% +0.003 pp | 0.15% -0.037 pp | USD9.00 +52.6% | 24 qtrs — |
| 14 | PANDORA WEALTH, INC. | 51.5K +— (+0.0%) | 706.4K -204.3K (-22.4%) | 0.08% 0.000 pp | 0.43% -0.122 pp | USD16.09 -14.7% | 4 qtrs — |
| 15 | NUVEEN, LLC | 48.2K +— (+0.0%) | 661.6K -191.3K (-22.4%) | 0.07% 0.000 pp | 0.00% 0.000 pp | USD16.09 -14.7% | 4 qtrs — |
| 16 | MORGAN STANLEY | 42.4K +4.8K (+12.7%) | 582.1K -84.0K (-12.6%) | 0.06% +0.007 pp | 0.00% +0.000 pp | USD13.84 -0.8% | 36 qtrs — |
| 17 | SWISS NATIONAL BANK | 39.1K +— (+0.0%) | 536.8K -155.2K (-22.4%) | 0.06% 0.000 pp | 0.00% 0.000 pp | USD17.05 -19.5% | 6 qtrs — |
| 18 | BANK OF NEW YORK MELLON CORP | 38.6K -449.0 (-1.2%) | 529.4K -161.0K (-23.3%) | 0.06% -0.001 pp | 0.00% +0.000 pp | USD8.19 +67.6% | 11 qtrs — |
| 19 | PANORAMIC CAPITAL, LLC | 38.1K +2.1K (+5.7%) | 522.5K -114.6K (-18.0%) | 0.06% +0.003 pp | 0.28% -0.006 pp | USD17.21 -20.2% | 5 qtrs — |
| 20 | INSPIRE INVESTING, LLC | 34.2K +8.6K (+33.4%) | 469.5K +15.8K (+3.5%) | 0.05% +0.013 pp | 0.04% -0.002 pp | USD12.33 +11.4% | 9 qtrs — |
| 21 | UBS ASSET MANAGEMENT AMERICAS INC | 30.7K +225.0 (+0.7%) | 421.5K -117.9K (-21.9%) | 0.05% +0.000 pp | 0.00% +0.000 pp | USD16.91 -18.8% | 6 qtrs — |
| 22 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 28.4K -1.0K (-3.4%) | 389.9K -130.4K (-25.1%) | 0.04% -0.002 pp | 0.00% +0.000 pp | USD5.90 +132.7% | 14 qtrs — |
| 23 | TUDOR INVESTMENT CORP ET AL | 27.8K +27.8K (+100.0%) | 381.6K +381.6K (+100.0%) | 0.04% +0.041 pp | 0.00% +0.001 pp | USD13.73 +0.0% | 1 qtrs NEW |
| 24 | BARCLAYS PLC | 27.7K -2.7K (-8.8%) | 379.7K -151.9K (-28.6%) | 0.04% -0.004 pp | 0.00% +0.000 pp | USD16.05 -14.5% | 36 qtrs — |
| 25 | TIAA TRUST, NATIONAL ASSOCIATION | 27.3K +— (+0.0%) | 374.8K -108.4K (-22.4%) | 0.04% 0.000 pp | 0.00% 0.000 pp | USD4.03 +240.7% | 10 qtrs — |
| 26 | EXODUSPOINT CAPITAL MANAGEMENT, LP | 25.1K +3.3K (+14.9%) | 344.9K -42.1K (-10.9%) | 0.04% +0.005 pp | 0.00% -0.001 pp | USD17.19 -20.1% | 2 qtrs — |
| 27 | RHUMBLINE ADVISERS | 23.1K -3.0K (-11.3%) | 317.4K -144.0K (-31.2%) | 0.03% -0.004 pp | 0.00% 0.000 pp | USD8.78 +56.4% | 11 qtrs — |
| 28 | GOLDMAN SACHS GROUP INC | 22.5K +5.3K (+31.1%) | 308.3K +5.1K (+1.7%) | 0.03% +0.008 pp | 0.00% +0.000 pp | USD16.66 -17.6% | 8 qtrs — |
| 29 | WELLS FARGO & COMPANY/MN | 22.1K +8.5K (+62.3%) | 304.1K +62.6K (+25.9%) | 0.03% +0.013 pp | 0.00% +0.000 pp | USD13.59 +1.0% | 36 qtrs — |
| 30 | DEUTSCHE BANK AG\ | 21.5K +5.3K (+33.0%) | 295.4K +9.0K (+3.1%) | 0.03% +0.008 pp | 0.00% +0.000 pp | USD15.15 -9.4% | 9 qtrs — |
| 31 | WEALTHTRUST AXIOM LLC | 21.5K +— (+0.0%) | 295.2K -85.4K (-22.4%) | 0.03% 0.000 pp | 0.08% -0.026 pp | USD2.77 +395.7% | 13 qtrs — |
| 32 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 21.2K +4.0K (+23.2%) | 290.6K -13.4K (-4.4%) | 0.03% +0.006 pp | 0.00% +0.000 pp | USD16.18 -15.1% | 11 qtrs — |
| 33 | ALLIANCEBERNSTEIN L.P. | 20.6K +— (+0.0%) | 283.1K -81.9K (-22.4%) | 0.03% +0.000 pp | 0.00% +0.000 pp | USD13.36 +2.8% | 7 qtrs — |
| 34 | FARTHER FINANCE ADVISORS, LLC | 20.4K +5.7K (+39.2%) | 279.7K +20.6K (+8.0%) | 0.03% +0.009 pp | 0.00% -0.001 pp | USD14.14 -2.9% | 8 qtrs — |
| 35 | CITADEL ADVISORS LLC | 18.8K -5.2K (-21.7%) | 258.1K -166.7K (-39.2%) | 0.03% -0.008 pp | 0.00% +0.000 pp | USD10.60 +29.5% | 13 qtrs — |
| 36 | SANCTUARY ADVISORS, LLC | 17.8K +17.8K (+100.0%) | 243.8K +243.8K (+100.0%) | 0.03% +0.026 pp | 0.00% +0.001 pp | USD13.73 +0.0% | 1 qtrs NEW |
| 37 | CREATIVE PLANNING | 17.2K -2.1K (-10.7%) | 236.7K -105.0K (-30.7%) | 0.03% -0.003 pp | 0.00% 0.000 pp | USD14.60 -6.0% | 7 qtrs — |
| 38 | STATE OF WISCONSIN INVESTMENT BOARD | 16.9K -3.6K (-17.8%) | 231.6K -131.4K (-36.2%) | 0.03% -0.006 pp | 0.00% 0.000 pp | USD17.52 -21.6% | 6 qtrs — |
| 39 | QUOTIENT WEALTH PARTNERS, LLC | 15.9K +15.9K (+100.0%) | 218.4K +218.4K (+100.0%) | 0.02% +0.024 pp | 0.01% +0.006 pp | USD13.73 +0.0% | 1 qtrs NEW |
| 40 | LEGAL & GENERAL GROUP PLC | 15.6K -73.0 (-0.5%) | 214.5K -63.3K (-22.8%) | 0.02% 0.000 pp | 0.00% +0.000 pp | USD15.92 -13.8% | 11 qtrs — |
| 41 | AIRE ADVISORS, LLC | 14.4K +14.4K (+100.0%) | 197.9K +197.9K (+100.0%) | 0.02% +0.021 pp | 0.04% +0.036 pp | USD13.73 +0.0% | 1 qtrs NEW |
| 42 | FMR LLC | 14.1K +891.0 (+6.7%) | 194.1K -40.4K (-17.2%) | 0.02% +0.001 pp | 0.00% +0.000 pp | USD12.40 +10.7% | 11 qtrs — |
| 43 | FOURTHOUGHT FINANCIAL PARTNERS, LLC | 13.7K -6.3K (-31.6%) | 188.4K -166.5K (-46.9%) | 0.02% -0.009 pp | 0.02% -0.015 pp | USD17.70 -22.4% | 2 qtrs — |
| 44 | OPPENHEIMER & CO INC | 12.9K +— (+0.0%) | 176.4K -51.0K (-22.4%) | 0.02% +0.000 pp | 0.00% 0.000 pp | USD17.41 -21.1% | 5 qtrs — |
| 45 | PRICE T ROWE ASSOCIATES INC /MD/ | 11.2K +330.0 (+3.0%) | 155.0K -38.0K (-19.7%) | 0.02% +0.001 pp | 0.00% +0.000 pp | USD15.17 -9.5% | 3 qtrs — |
| 46 | METLIFE INVESTMENT MANAGEMENT, LLC | 10.1K +— (+0.0%) | 138.6K -40.1K (-22.4%) | 0.02% +0.000 pp | 0.00% 0.000 pp | USD12.10 +13.5% | 9 qtrs — |
| 47 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 10.0K -348.0 (-3.4%) | 137.8K -46.0K (-25.0%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD15.09 -9.0% | 3 qtrs — |
| 48 | QUEST PARTNERS LLC | 8.9K -4.8K (-35.2%) | 121.7K -120.6K (-49.8%) | 0.01% -0.007 pp | 0.01% -0.009 pp | USD15.52 -11.5% | 7 qtrs — |
| 49 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 8.2K +125.0 (+1.5%) | 112.9K -30.4K (-21.2%) | 0.01% +0.000 pp | 0.00% 0.000 pp | USD11.36 +20.9% | 7 qtrs — |
| 50 | JPMORGAN CHASE & CO | 7.1K -955.0 (-11.8%) | 97.6K -45.1K (-31.6%) | 0.01% -0.001 pp | 0.00% +0.000 pp | USD9.14 +50.2% | 11 qtrs — |
| 51 | PNC FINANCIAL SERVICES GROUP, INC. | 5.6K -15.0 (-0.3%) | 76.5K -22.4K (-22.6%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD16.09 -14.7% | 9 qtrs — |
| 52 | RUSSELL INVESTMENTS GROUP, LTD. | 5.1K +619.0 (+13.8%) | 70.1K -9.3K (-11.7%) | 0.01% +0.001 pp | 0.00% +0.000 pp | USD13.66 +0.5% | 9 qtrs — |
| 53 | NEW YORK STATE COMMON RETIREMENT FUND | 4.7K +— (+0.0%) | 63.9K -18.5K (-22.4%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD7.20 +90.7% | 11 qtrs — |
| 54 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 4.6K +— (+0.0%) | 63.7K -18.4K (-22.4%) | 0.01% +0.000 pp | 0.00% 0.000 pp | USD17.47 -21.4% | 5 qtrs — |
| 55 | KLP KAPITALFORVALTNING AS | 4.3K -1.6K (-27.1%) | 59.0K -45.4K (-43.5%) | 0.01% -0.002 pp | 0.00% 0.000 pp | USD17.58 -21.9% | 5 qtrs — |
| 56 | BNP PARIBAS ARBITRAGE, SNC | 3.8K +329.0 (+9.5%) | 52.3K -9.3K (-15.1%) | 0.01% +0.001 pp | 0.00% +0.000 pp | USD14.01 -2.0% | 35 qtrs — |
| 57 | TOWER RESEARCH CAPITAL LLC (TRC) | 2.0K -1.0K (-33.5%) | 27.5K -25.9K (-48.4%) | 0.00% -0.002 pp | 0.00% -0.001 pp | USD14.76 -7.0% | 11 qtrs — |
| 58 | ADVISOR GROUP HOLDINGS, INC. | 1.9K -582.0 (-23.3%) | 26.4K -18.1K (-40.8%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD8.88 +54.6% | 24 qtrs — |
| 59 | AMERITAS INVESTMENT PARTNERS, INC. | 1.9K +— (+0.0%) | 25.6K -7.4K (-22.4%) | 0.00% +0.000 pp | 0.00% 0.000 pp | USD9.72 +41.3% | 11 qtrs — |
| 60 | ROYAL BANK OF CANADA | 1.6K -34.5K (-95.5%) | 22.0K -618.0K (-96.6%) | 0.00% -0.051 pp | 0.00% 0.000 pp | USD16.14 -14.9% | 13 qtrs — |
| 61 | OSTERWEIS CAPITAL MANAGEMENT INC | 1.0K +— (+0.0%) | 13.7K -4.0K (-22.4%) | 0.00% +0.000 pp | 0.00% 0.000 pp | USD2.30 +497.0% | 14 qtrs — |
| 62 | CIBC PRIVATE WEALTH GROUP, LLC | 1.0K +1.0K (+100.0%) | 13.7K +13.7K (+100.0%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD13.73 +0.0% | 1 qtrs NEW |
| 63 | AMALGAMATED BANK | 557.00 -75.0 (-11.9%) | 8.0K -3.0K (-27.3%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD8.41 +63.3% | 11 qtrs — |
| 64 | GROUP ONE TRADING, L.P. | 575.00 +575.0 (+100.0%) | 7.9K +7.9K (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD13.73 +0.0% | 1 qtrs NEW |
| 65 | CITIGROUP INC | 516.00 -1.5K (-74.2%) | 7.1K -28.3K (-80.0%) | 0.00% -0.002 pp | 0.00% +0.000 pp | USD15.90 -13.6% | 11 qtrs — |
| 66 | NATIONAL BANK OF CANADA /FI/ | 500.00 +— (+0.0%) | 6.9K -2.0K (-22.2%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD4.24 +223.8% | 13 qtrs — |
| 67 | OPTIVER HOLDING B.V. | 296.00 +— (+0.0%) | 4.1K -1.2K (-22.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD17.70 -22.4% | 2 qtrs — |
| 68 | SRS CAPITAL ADVISORS, INC. | 244.00 -81.0 (-24.9%) | 3.4K -2.4K (-41.7%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD17.70 -22.4% | 2 qtrs — |
| 69 | STEWARD PARTNERS INVESTMENT ADVISORY, LLC | 178.00 +— (+0.0%) | 2.4K -707.0 (-22.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD7.55 +81.9% | 13 qtrs — |
| 70 | CGC FINANCIAL SERVICES, LLC | 133.00 +— (+0.0%) | 1.8K -528.0 (-22.4%) | 0.00% +0.000 pp | 0.00% 0.000 pp | USD7.98 +72.1% | 8 qtrs — |
| 71 | STERLING CAPITAL MANAGEMENT LLC | 115.00 +72.0 (+167.4%) | 1.6K +818.0 (+107.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD14.63 -6.2% | 6 qtrs — |
| 72 | GAMMA INVESTING LLC | 107.00 -14.0 (-11.6%) | 1.5K -673.0 (-31.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD17.02 -19.3% | 6 qtrs — |
| 73 | ASTER CAPITAL MANAGEMENT (DIFC) LTD | 61.00 -173.0 (-73.9%) | 838.00 -3.3K (-79.8%) | 0.00% 0.000 pp | 0.00% -0.002 pp | USD16.11 -14.8% | 6 qtrs — |
| 74 | TD CAPITAL MANAGEMENT LLC | 40.00 +— (+0.0%) | 549.00 -159.0 (-22.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD16.08 -14.6% | 4 qtrs — |
| 75 | LARSON FINANCIAL GROUP LLC | 33.00 -149.0 (-81.9%) | 453.00 -2.8K (-85.9%) | 0.00% 0.000 pp | 0.00% 0.000 pp | USD17.70 -22.4% | 2 qtrs — |
| 76 | STONE HOUSE INVESTMENT MANAGEMENT, LLC | 32.00 +32.0 (+100.0%) | 439.00 +439.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD13.72 +0.1% | 1 qtrs NEW |
| 77 | NISA INVESTMENT ADVISORS, LLC | 26.00 +— (+0.0%) | 357.00 -103.0 (-22.4%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD14.23 -3.5% | 8 qtrs — |
| 78 | ALLWORTH FINANCIAL LP | 17.00 -153.0 (-90.0%) | 234.00 -2.8K (-92.2%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD17.53 -21.7% | 3 qtrs — |
| 79 | GLOBAL RETIREMENT PARTNERS, LLC | 15.00 +— (+0.0%) | 206.00 -60.0 (-22.6%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD17.67 -22.3% | 2 qtrs — |
| 80 | SIMPLEX TRADING, LLC | — -205.0 (-100.0%) | — -3.0K (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 27 qtrs SOLD |
| 81 | FRANKLIN RESOURCES INC | — -12.1K (-100.0%) | — -214.5K (-100.0%) | 0.00% -0.018 pp | 0.00% 0.000 pp | USD— | 6 qtrs SOLD |
| 82 | US BANCORP \DE\ | — -2.0 (-100.0%) | — -35.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 6 qtrs SOLD |
| 83 | FNY INVESTMENT ADVISERS, LLC | — -86.0 (-100.0%) | — -1.0K (-100.0%) | 0.00% 0.000 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
| 84 | EVERSOURCE WEALTH ADVISORS, LLC | — -24.0 (-100.0%) | — -425.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 5 qtrs SOLD |
| 85 | BENDER ROBERT & ASSOCIATES | — -11.6K (-100.0%) | — -205.1K (-100.0%) | 0.00% -0.017 pp | 0.00% -0.044 pp | USD— | 5 qtrs SOLD |
| 86 | AQUATIC CAPITAL MANAGEMENT LLC | — -2.0 (-100.0%) | — -35.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 87 | JANE STREET GROUP, LLC | — -34.2K (-100.0%) | — -604.5K (-100.0%) | 0.00% -0.051 pp | 0.00% 0.000 pp | USD— | 9 qtrs SOLD |
| 88 | STRS OHIO | — -19.2K (-100.0%) | — -339.8K (-100.0%) | 0.00% -0.029 pp | 0.00% -0.001 pp | USD— | 6 qtrs SOLD |
| 89 | SBI SECURITIES CO., LTD. | — -5.0 (-100.0%) | — -89.0 (-100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD— | 5 qtrs SOLD |
| 90 | SALEM INVESTMENT COUNSELORS INC | — -150.0 (-100.0%) | — -2.7K (-100.0%) | 0.00% 0.000 pp | 0.00% 0.000 pp | USD— | 3 qtrs SOLD |
| 91 | LPL FINANCIAL LLC | — -12.3K (-100.0%) | — -217.6K (-100.0%) | 0.00% -0.018 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 70 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | State Street SPDR S&P Health Care Equipment ETF XHE | 0.88% | 1.34M | 0.35% |
| 2 | Inspire Small/Mid Cap ETF ISMD | 0.19% | 617.8K | 0.53% |
| 3 | iShares Micro-Cap ETF IWC | 0.11% | 1.63M | 0.60% |
| 4 | iShares Russell 2000 Growth ETF IWO | 0.03% | 4.59M | 0.24% |
| 5 | Vanguard Global Momentum Factor ETF VMO.TO | 0.03% | 98.6K | 0.38% |
| 6 | Vanguard Russell 2000 Growth ETF VTWG | 0.02% | 414.2K | 0.06% |
| 7 | State Street SPDR Russell 2000 U.S. Small Cap UCITS ETF (Acc) R2US.L | 0.02% | 960.6K | 0.30% |
| 8 | Xtrackers Russell 2000 UCITS ETF 1C XRSU.L | 0.02% | 492.6K | 0.30% |
| 9 | iShares Morningstar Small Cap Value ETF ISCV | 0.02% | 114.6K | 0.06% |
| 10 | iShares Russell 2000 BuyWrite ETF IWMW | 0.02% | 8.9K | 0.39% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.33
Bearish
Ratio by volume
0.39
Bearish
Buys
4
Sells
12
Shares acquired
93.1K
Shares disposed
240.0K
Cash buys
—
Cash sales
6.00
Net activity
-146,896
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-23 | UECKER DARRIN | Director / Officer | A-Award | A | Restricted Stock Units | 100,000 | 0.00 | — | 100,000 | D | ↗ |
| 2026-02-18 | Danahy Kevin Patrick | Officer | M-Exempt | D | Stock Option (right to buy) | 5,000 | 1.53 | 7.7K | 300,000 | D | ↗ |
| 2026-02-17 | Danahy Kevin Patrick | Officer | M-Exempt | D | Stock Option (right to buy) | 20,000 | 1.53 | 30.6K | 305,000 | D | ↗ |
| 2026-02-13 | Danahy Kevin Patrick | Officer | M-Exempt | D | Stock Option (right to buy) | 20,000 | 1.53 | 30.6K | 325,000 | D | ↗ |
| 2026-02-12 | Danahy Kevin Patrick | Officer | M-Exempt | D | Stock Option (right to buy) | 20,000 | 1.53 | 30.6K | 345,000 | D | ↗ |
| 2026-02-11 | Danahy Kevin Patrick | Officer | M-Exempt | A | Common Stock | 20,000 | 1.53 | 30.6K | 63,298 | D | ↗ |
| 2026-02-10 | Danahy Kevin Patrick | Officer | M-Exempt | D | Stock Option (right to buy) | 20,000 | 1.53 | 30.6K | 385,000 | D | ↗ |
| 2026-02-09 | Danahy Kevin Patrick | Officer | S-Sale | D | Common Stock | 20,000 | 21.45 | 429.0K | 43,298 | D | ↗ |
| 2026-02-05 | Sainz Maria | Director | A-Award | A | Stock Option (right to buy) | 3,104 | 13.69 | 42.5K | 3,104 | D | ↗ |
| 2026-01-08 | Sainz Maria | Director | A-Award | A | Stock Option (right to buy) | 50,000 | 14.72 | 736.0K | 50,000 | D | ↗ |
| 2025-10-02 | Danahy Kevin Patrick | Officer | M-Exempt | D | Stock Option (right to buy) | 4,600 | 1.53 | 7.0K | 425,000 | D | ↗ |
| 2025-09-19 | Danahy Kevin Patrick | Officer | M-Exempt | A | Common Stock | 400 | 1.53 | 612.00 | 43,698 | D | ↗ |
| 2025-09-18 | Danahy Kevin Patrick | Officer | S-Sale | D | Common Stock | 20,000 | 18.49 | 369.8K | 43,298 | D | ↗ |
| 2025-09-17 | UECKER DARRIN | Director / Officer | M-Exempt | D | Stock Option (right to buy) | 100,000 | 4.00 | 400.0K | 0 | D | ↗ |
| 2025-09-16 | UECKER DARRIN | Director / Officer | M-Exempt | A | Common Stock | 25,000 | 4.00 | 100.0K | 147,872 | D | ↗ |
| 2025-09-15 | UECKER DARRIN | Director / Officer | S-Sale | D | Common Stock | 25,000 | 15.77 | 394.3K | 122,872 | D | ↗ |
| 2025-09-12 | UECKER DARRIN | Director / Officer | S-Sale | D | Common Stock | 25,000 | 14.32 | 358.0K | 122,872 | D | ↗ |
| 2025-09-11 | UECKER DARRIN | Director / Officer | S-Sale | D | Common Stock | 25,000 | 14.78 | 369.5K | 122,872 | D | ↗ |
| 2025-09-10 | DUGGAN ROBERT W | Director / 10% Owner | P-Purchase | A | Common Stock | 34,659 | 14.66 | 508.1K | 47,551,200 | D | ↗ |
| 2025-08-15 | van den Broek Richard | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 16.16 | 484.8K | 30,000 | D | ↗ |
| 2025-08-15 | Zanganeh Mahkam | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 16.16 | 484.8K | 30,000 | D | ↗ |
| 2025-08-15 | Soni Manmeet Singh | Director | A-Award | A | Stock Option (right to buy) | 30,000 | 16.16 | 484.8K | 30,000 | D | ↗ |
| 2025-08-15 | DUGGAN ROBERT W | Director / 10% Owner | A-Award | A | Stock Option (right to buy) | 30,000 | 16.16 | 484.8K | 30,000 | D | ↗ |
| 2025-07-14 | Weber Steven | Officer | A-Award | A | Stock Option (right to buy) | 55,000 | 16.03 | 881.7K | 55,000 | D | ↗ |
| 2025-06-13 | UECKER DARRIN | Director / Officer | S-Sale | D | Common Stock | 15,000 | 15.98 | 239.7K | 122,872 | D | ↗ |
| 2025-06-12 | UECKER DARRIN | Director / Officer | S-Sale | D | Common Stock | 15,000 | 16.40 | 246.0K | 137,872 | D | ↗ |
| 2025-02-03 | Zanganeh Mahkam | Director | X-InTheMoney | A | Common Stock | 30,121 | 11.00 | 331.3K | 725,395 | D | ↗ |
| 2025-01-24 | Zanganeh Mahkam | Director | X-InTheMoney | A | Common Stock | 30,121 | 11.00 | 331.3K | 695,274 | D | ↗ |
| 2025-01-09 | LAVIOLETTE PAUL A | Director / Officer | A-Award | A | Stock Option (right to buy) | 1,050,000 | 18.43 | 19.35M | 1,050,000 | D | ↗ |
| 2024-12-18 | DUGGAN ROBERT W | Director / 10% Owner | X-InTheMoney | A | Common Stock | 69,020 | 11.00 | 759.2K | 630,109 | I | ↗ |
| 2024-12-13 | DUGGAN ROBERT W | Director / 10% Owner | P-Purchase | A | Common Stock | 55,256 | 17.18 | 949.3K | 42,328,717 | D | ↗ |
| 2024-12-11 | DUGGAN ROBERT W | Director / 10% Owner | P-Purchase | A | Common Stock | 50,000 | 17.42 | 871.0K | 42,228,057 | D | ↗ |
| 2024-12-11 | Barrett Burke Thomas | Other | S-Sale | D | Common Stock | 50,000 | 17.42 | 871.0K | 63,172 | D | ↗ |
| 2024-09-24 | Levinson Mitchell E. | Officer | X-InTheMoney | D | Warrant (right to buy) | 620 | 11.00 | 6.8K | 1 | I | ↗ |
| 2024-09-12 | DUGGAN ROBERT W | Director / 10% Owner | P-Purchase | A | Common Stock | 145,140 | 14.41 | 2.09M | 47,709,140 | D | ↗ |
| 2024-09-11 | DUGGAN ROBERT W | Director / 10% Owner | P-Purchase | A | Common Stock | 12,800 | 14.77 | 189.1K | 47,564,000 | D | ↗ |
| 2024-08-09 | Zanganeh Mahkam | Director | A-Award | A | Stock Option (right to buy) | 200,000 | 15.65 | 3.13M | 200,000 | — | ↗ |
| 2024-08-09 | Soni Manmeet Singh | Director | A-Award | A | Stock Option (right to buy) | 200,000 | 15.65 | 3.13M | 200,000 | — | ↗ |
| 2024-08-09 | LAVIOLETTE PAUL A | Director | A-Award | A | Stock Option (right to buy) | 200,000 | 15.65 | 3.13M | 200,000 | — | ↗ |
| 2024-07-19 | Barrett Burke Thomas | Director / Officer | X-InTheMoney | A | Common Stock | 543 | 11.00 | 6.0K | 11,629 | — | ↗ |
| 2024-07-03 | Zanganeh Mahkam | Director | P-Purchase | A | Warrant (right to buy) | 30,121 | 11.00 | 331.3K | 30,121 | — | ↗ |
| 2024-07-03 | Levinson Mitchell E. | Officer | P-Purchase | A | Warrant (right to buy) | 161 | 11.00 | 1.8K | 161 | — | ↗ |
| 2024-07-03 | Danahy Kevin Patrick | Officer | P-Purchase | A | Warrant (right to buy) | 325 | 11.00 | 3.6K | 325 | — | ↗ |
| 2024-07-03 | DUGGAN ROBERT W | Director / 10% Owner | P-Purchase | A | Warrant (right to buy) | 34,510 | 11.00 | 379.6K | 34,510 | — | ↗ |
| 2024-07-03 | Barrett Burke Thomas | Director / Officer | P-Purchase | A | Warrant (right to buy) | 543 | 11.00 | 6.0K | 543 | — | ↗ |
| 2024-06-06 | van den Broek Richard | Director | A-Award | A | Stock Option (right to buy) | 11,649 | 14.55 | 169.5K | 11,649 | — | ↗ |
| 2024-06-06 | Zanganeh Mahkam | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 14.55 | 291.0K | 20,000 | — | ↗ |
| 2024-06-06 | Soni Manmeet Singh | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 14.55 | 291.0K | 20,000 | — | ↗ |
| 2024-06-06 | DUGGAN ROBERT W | Director / 10% Owner | A-Award | A | Stock Option (right to buy) | 16,247 | 14.55 | 236.4K | 16,247 | — | ↗ |
| 2024-05-20 | Barrett Burke Thomas | Director / Officer | P-Purchase | A | Common Stock | 10,000 | 8.56 | 85.6K | 10,000 | — | ↗ |
| 2024-05-12 | Barrett Burke Thomas | Director / Officer | A-Award | A | Stock Option (right to buy) | 700,000 | 7.45 | 5.22M | 700,000 | — | ↗ |
| 2023-12-12 | DUGGAN ROBERT W | Director / 10% Owner | P-Purchase | A | Common Stock | 17,999 | 9.15 | 164.7K | 36,984,179 | — | ↗ |
| 2023-12-11 | DUGGAN ROBERT W | Director / 10% Owner | P-Purchase | A | Common Stock | 90,118 | 9.36 | 843.5K | 36,966,180 | — | ↗ |
| 2023-12-08 | DUGGAN ROBERT W | Director / 10% Owner | P-Purchase | A | Common Stock | 116,656 | 9.54 | 1.11M | 36,876,062 | — | ↗ |
| 2023-12-07 | DUGGAN ROBERT W | Director / 10% Owner | P-Purchase | A | Common Stock | 74,852 | 9.19 | 687.9K | 36,759,406 | — | ↗ |
| 2023-12-06 | DUGGAN ROBERT W | Director / 10% Owner | P-Purchase | A | Common Stock | 82,813 | 9.06 | 750.3K | 36,684,554 | — | ↗ |
| 2023-12-05 | DUGGAN ROBERT W | Director / 10% Owner | P-Purchase | A | Common Stock | 66,021 | 9.34 | 616.6K | 351,565 | — | ↗ |
| 2023-12-04 | DUGGAN ROBERT W | Director / 10% Owner | M-Exempt | A | Common Stock | 20,347 | 10.66 | 216.9K | 36,591,808 | — | ↗ |
| 2023-12-01 | DUGGAN ROBERT W | Director / 10% Owner | P-Purchase | A | Common Stock | 45,600 | 9.07 | 413.6K | 258,544 | — | ↗ |
| 2023-11-30 | DUGGAN ROBERT W | Director / 10% Owner | P-Purchase | A | Common Stock | 152,944 | 9.06 | 1.39M | 212,944 | — | ↗ |
| 2023-11-29 | DUGGAN ROBERT W | Director / 10% Owner | M-Exempt | D | Stock Option (right to buy) | 1,667 | 5.95 | 9.9K | 10,000 | — | ↗ |
| 2023-11-28 | DUGGAN ROBERT W | Director / 10% Owner | P-Purchase | A | Common Stock | 124,397 | 8.98 | 1.12M | 36,391,194 | — | ↗ |
| 2023-11-17 | DUGGAN ROBERT W | Director / 10% Owner | P-Purchase | A | Common Stock | 10,000 | 6.11 | 61.1K | 36,266,797 | — | ↗ |
| 2023-11-16 | Danahy Kevin Patrick | Officer | P-Purchase | A | Common Stock | 12 | 6.50 | 78.00 | 35,887 | — | ↗ |
| 2023-11-15 | Levinson Mitchell E. | Officer | P-Purchase | A | Common Stock | 100 | 5.94 | 594.00 | 834 | — | ↗ |
| 2023-11-13 | Zanganeh Mahkam | Director | M-Exempt | A | Common Stock | 56,075 | 2.14 | 120.0K | 604,911 | — | ↗ |
| 2023-11-07 | DUGGAN ROBERT W | Director / 10% Owner | M-Exempt | A | Common Stock | 9,932 | 5.95 | 59.1K | 36,246,556 | — | ↗ |
| 2023-11-01 | UECKER DARRIN | Director / Officer | A-Award | A | Stock Option (right to buy) | 330,000 | 4.38 | 1.45M | 330,000 | — | ↗ |
| 2023-11-01 | Levinson Mitchell E. | Officer | A-Award | A | Stock Option (right to buy) | 100,000 | 4.38 | 438.0K | 100,000 | — | ↗ |
| 2023-11-01 | Danahy Kevin Patrick | Officer | J-Other | D | Stock Option (right to buy) | 130,000 | 3.96 | 514.8K | 0 | — | ↗ |
| 2023-10-23 | Danahy Kevin Patrick | Officer | A-Award | A | Stock Option (right to buy) | 130,000 | 3.96 | 514.8K | 130,000 | — | ↗ |
| 2023-08-25 | DUGGAN ROBERT W | Director / 10% Owner | M-Exempt | A | Common Stock | 1,667 | 5.95 | 9.9K | 36,233,291 | — | ↗ |
| 2023-07-25 | DUGGAN ROBERT W | Director / 10% Owner | M-Exempt | A | Common Stock | 1,667 | 5.95 | 9.9K | 36,231,624 | — | ↗ |
| 2023-07-12 | UECKER DARRIN | Director / Officer | A-Award | A | Stock Option (right to buy) | 200,000 | 7.08 | 1.42M | 200,000 | — | ↗ |
| 2023-07-12 | Levinson Mitchell E. | Officer | A-Award | A | Stock Option (right to buy) | 100,000 | 7.08 | 708.0K | 100,000 | — | ↗ |
| 2023-07-12 | Danahy Kevin Patrick | Officer | A-Award | A | Stock Option (right to buy) | 200,000 | 7.08 | 1.42M | 200,000 | — | ↗ |
| 2023-07-07 | DUGGAN ROBERT W | Director / 10% Owner | M-Exempt | A | Common Stock | 65,467 | 2.14 | 140.1K | 36,228,291 | — | ↗ |
| 2023-07-05 | DUGGAN ROBERT W | Director / 10% Owner | M-Exempt | A | Common Stock | 65,000 | 2.14 | 139.1K | 36,162,824 | — | ↗ |
| 2023-06-14 | DUGGAN ROBERT W | Director / 10% Owner | X-InTheMoney | D | Warrant (right to buy) | 81,025 | 2.05 | 166.1K | 0 | — | ↗ |
| 2023-06-12 | UECKER DARRIN | Director / Officer | X-InTheMoney | A | Common Stock | 7,365 | 2.05 | 15.1K | 877,636 | D | ↗ |
| 2023-06-09 | Zanganeh Mahkam | Director | X-InTheMoney | A | Common Stock | 86,668 | 2.05 | 177.7K | 528,836 | — | ↗ |
| 2023-05-25 | van den Broek Richard | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 5.95 | 119.0K | 20,000 | — | ↗ |
| 2023-05-25 | Zanganeh Mahkam | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 5.95 | 119.0K | 20,000 | — | ↗ |
| 2023-05-25 | Spray Shelley D | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 5.95 | 119.0K | 20,000 | — | ↗ |
| 2023-05-25 | Soni Manmeet Singh | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 5.95 | 119.0K | 20,000 | — | ↗ |
| 2023-05-25 | Levinson Mitchell E. | Officer | X-InTheMoney | A | Common Stock | 143 | 2.05 | 293.15 | 734 | — | ↗ |
| 2023-05-25 | DUGGAN ROBERT W | Director / 10% Owner | A-Award | A | Stock Option (right to buy) | 20,000 | 5.95 | 119.0K | 20,000 | — | ↗ |
| 2023-05-09 | DUGGAN ROBERT W | Director / 10% Owner | P-Purchase | A | Common Stock | 10,022,937 | 6.51 | 65.25M | 30,414,661 | — | ↗ |
| 2023-05-08 | Levinson Mitchell E. | Director / Officer | A-Award | A | Stock Option (right to buy) | 17,700 | 8.02 | 142.0K | 17,700 | — | ↗ |
| 2023-04-29 | UECKER DARRIN | Officer | A-Award | A | Stock Option (right to buy) | 500,000 | 6.44 | 3.22M | 500,000 | — | ↗ |
| 2023-04-29 | Danahy Kevin Patrick | Officer | A-Award | A | Stock Option (right to buy) | 500,000 | 6.44 | 3.22M | 500,000 | — | ↗ |
| 2023-04-17 | Levinson Mitchell E. | Director / Officer | A-Award | A | Stock Option (right to buy) | 2,000 | 5.81 | 11.6K | 2,000 | — | ↗ |
| 2023-03-22 | Levinson Mitchell E. | Officer | A-Award | A | Stock Option (right to buy) | 35,000 | 2.92 | 102.2K | 35,000 | — | ↗ |
| 2023-03-17 | Danahy Kevin Patrick | Officer | A-Award | A | Stock Option (right to buy) | 25,000 | 6.41 | 160.3K | 25,000 | — | ↗ |
| 2022-10-07 | Levinson Mitchell E. | Officer | P-Purchase | A | Common Stock | 4,500 | 2.23 | 10.0K | 5,234 | — | ↗ |
| 2022-09-30 | Danahy Kevin Patrick | Officer | P-Purchase | A | Common Stock | 6,500 | 2.30 | 15.0K | 6,500 | — | ↗ |
| 2022-09-23 | Danahy Kevin Patrick | Officer | A-Award | A | Stock Option (right to buy) | 450,000 | 1.53 | 688.5K | 450,000 | — | ↗ |
| 2022-06-09 | Zanganeh Maky | Director | P-Purchase | A | Warrant (right to buy) | 86,668 | 0.00 | — | 86,668 | — | ↗ |
| 2022-06-09 | UECKER DARRIN | Director | P-Purchase | A | Warrant (right to buy) | 7,365 | 0.00 | — | 7,365 | — | ↗ |
| 2022-06-09 | Levinson Mitchell E. | Director / Officer | X-InTheMoney | A | Common Stock | 10,935 | 2.05 | 22.4K | 37,504 | — | ↗ |
| 2022-06-09 | DUGGAN ROBERT W | Director | P-Purchase | A | Warrant (right to buy) | 81,025 | 0.00 | — | 81,025 | — | ↗ |
| 2022-05-19 | van den Broek Richard | Director | A-Award | A | Stock Option (right to buy) | 79,206 | 0.00 | — | 79,206 | — | ↗ |
| 2022-05-19 | Zanganeh Maky | Director | A-Award | A | Stock Option (right to buy) | 56,075 | 2.14 | 120.0K | 56,075 | — | ↗ |
| 2022-05-19 | Spray Shelley D | Director | A-Award | A | Stock Option (right to buy) | 35,047 | 0.00 | — | 35,047 | — | ↗ |
| 2022-05-19 | Soni Manmeet Singh | Director | A-Award | A | Stock Option (right to buy) | 116,005 | 0.00 | — | 116,005 | — | ↗ |
| 2022-05-19 | DUGGAN ROBERT W | Director | A-Award | A | Stock Option (right to buy) | 110,467 | 0.00 | — | 110,467 | — | ↗ |
| 2022-02-14 | Danahy Kevin Patrick | Officer | A-Award | A | Stock Option (right to buy) | 300,000 | 6.41 | 1.92M | 300,000 | — | ↗ |
| 2021-12-14 | GARDINER SANDRA A. | Officer | A-Award | A | Stock Option (right to buy) | 25,961 | 13.94 | 361.9K | 51,922 | — | ↗ |
| 2021-11-24 | Spray Shelley D | Director | A-Award | A | Stock Option (right to buy) | 32,500 | 21.70 | 705.3K | 32,500 | — | ↗ |
| 2021-10-04 | DEBUONO LAUREEN | Director | A-Award | A | Stock Option (right to buy) | 32,500 | 20.33 | 660.7K | 32,500 | — | ↗ |
| 2021-08-19 | Levinson Mitchell E. | Director / Officer | A-Award | A | Stock Option (right to buy) | 65,510 | 21.12 | 1.38M | 65,510 | — | ↗ |
| 2021-06-30 | DUGGAN ROBERT W | Director / 10% Owner | P-Purchase | A | Common Stock | 3,048,780 | 16.40 | 50.00M | 14,708,561 | — | ↗ |
| 2021-06-01 | Ebbers Ed | Officer | F-InKind | D | Common Stock | 1,485 | 18.76 | 27.9K | 39,300 | — | ↗ |
| 2021-05-20 | van den Broek Richard | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 18.69 | 373.8K | 20,000 | — | ↗ |
| 2021-05-20 | Zanganeh Maky | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 18.69 | 373.8K | 20,000 | — | ↗ |
| 2021-05-20 | Soni Manmeet Singh | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 18.69 | 373.8K | 20,000 | — | ↗ |
| 2021-05-20 | Levinson Mitchell E. | Director | A-Award | A | Stock Option (right to buy) | 45,987 | 18.69 | 859.5K | 45,987 | — | ↗ |
| 2021-05-20 | DUGGAN ROBERT W | Director / 10% Owner | A-Award | A | Stock Option (right to buy) | 20,000 | 18.69 | 373.8K | 20,000 | — | ↗ |
| 2021-05-20 | Clark Kenneth A | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 18.69 | 373.8K | 20,000 | — | ↗ |
| 2021-03-22 | UECKER DARRIN | Director / Officer | A-Award | A | Stock Option (right to buy) | 54,750 | 24.03 | 1.32M | 54,750 | — | ↗ |
| 2021-03-22 | GARDINER SANDRA A. | Officer | A-Award | A | Stock Option (right to buy) | 18,000 | 24.03 | 432.5K | 18,000 | — | ↗ |
| 2021-03-22 | Ebbers Ed | Officer | A-Award | A | Stock Option (right to buy) | 15,875 | 24.03 | 381.5K | 15,875 | — | ↗ |
| 2021-02-23 | UECKER DARRIN | Director / Officer | A-Award | A | Stock Option (right to buy) | 37,500 | 10.66 | 399.8K | 37,500 | — | ↗ |
| 2021-02-23 | GARDINER SANDRA A. | Officer | A-Award | A | Stock Option (right to buy) | 8,750 | 10.66 | 93.3K | 8,750 | — | ↗ |
| 2021-02-23 | Ebbers Ed | Officer | A-Award | A | Stock Option (right to buy) | 37,500 | 10.66 | 399.8K | 37,500 | — | ↗ |
| 2021-01-25 | UECKER DARRIN | Director / Officer | X-InTheMoney | A | Common Stock | 1,284 | 7.01 | 9.0K | 127,893 | — | ↗ |
| 2021-01-20 | Levinson Mitchell E. | Director | X-InTheMoney | A | Common Stock | 107 | 7.01 | 750.07 | 3,321 | — | ↗ |
| 2021-01-19 | Zanganeh Maky | Director | X-InTheMoney | A | Common Stock | 307 | 7.01 | 2.2K | 107,074 | — | ↗ |
| 2021-01-08 | Zanganeh Maky | Director | X-InTheMoney | A | Common Stock | 3,000 | 7.01 | 21.0K | 355,500 | — | ↗ |
| 2020-12-29 | DUGGAN ROBERT W | Director / 10% Owner | X-InTheMoney | A | Common Stock | 8,214 | 7.01 | 57.6K | 330,019 | — | ↗ |
| 2020-12-09 | GARDINER SANDRA A. | Officer | A-Award | A | Stock Option (right to buy) | 25,961 | 13.94 | 361.9K | 25,961 | — | ↗ |
| 2020-10-08 | Levinson Mitchell E. | Director | X-InTheMoney | A | Common Stock | 856 | 7.01 | 6.0K | 26,569 | — | ↗ |
| 2020-08-06 | van den Broek Richard | Director | A-Award | A | Stock Option (right to buy) | 32,500 | 10.78 | 350.4K | 32,500 | — | ↗ |
| 2020-06-23 | Zanganeh Maky | Director | P-Purchase | A | Common Stock | 1,193 | 10.70 | 12.8K | 106,767 | — | ↗ |
| 2020-06-17 | Zanganeh Maky | Director | P-Purchase | A | Common Stock | 7,950 | 7.01 | 55.7K | 105,574 | — | ↗ |
| 2020-06-15 | Zanganeh Maky | Director | P-Purchase | A | Warrant (right to buy) | 307 | 7.01 | 2.2K | 307 | — | ↗ |
| 2020-06-15 | UECKER DARRIN | Director / Officer | X-InTheMoney | A | Common Stock | 8,563 | 7.01 | 60.0K | 126,609 | — | ↗ |
| 2020-06-15 | Levinson Mitchell E. | Director | P-Purchase | A | Warrant (right to buy) | 107 | 7.01 | 750.07 | 107 | — | ↗ |
| 2020-06-15 | DUGGAN ROBERT W | Director / 10% Owner | X-InTheMoney | A | Common Stock | 2,507,112 | 7.01 | 17.57M | 11,283,716 | — | ↗ |
| 2020-05-18 | Zanganeh Maky | Director | A-Award | A | Stock Option (right to buy) | 14,071 | 10.66 | 150.0K | 14,071 | — | ↗ |
| 2020-05-18 | Soni Manmeet Singh | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 10.66 | 213.2K | 20,000 | — | ↗ |
| 2020-05-18 | Levinson Mitchell E. | Director | A-Award | A | Stock Option (right to buy) | 15,901 | 10.66 | 169.5K | 15,901 | — | ↗ |
| 2020-05-18 | DUGGAN ROBERT W | Director / 10% Owner | A-Award | A | Stock Option (right to buy) | 20,000 | 10.66 | 213.2K | 20,000 | — | ↗ |
| 2020-05-18 | Clark Kenneth A | Director | A-Award | A | Stock Option (right to buy) | 14,071 | 10.66 | 150.0K | 14,071 | — | ↗ |
| 2019-11-18 | GARDINER SANDRA A. | Officer | A-Award | A | Stock Option (right to buy) | 103,842 | 13.94 | 1.45M | 103,842 | — | ↗ |
| 2019-06-03 | UECKER DARRIN | Director / Officer | F-InKind | D | Common Stock | 36,321 | 11.51 | 418.1K | 118,046 | — | ↗ |
| 2019-06-03 | Ebbers Ed | Officer | F-InKind | D | Common Stock | 2,671 | 11.51 | 30.7K | 37,932 | — | ↗ |
| 2019-05-16 | Zanganeh Maky | Director | A-Award | A | Stock Option (right to buy) | 9,210 | 13.03 | 120.0K | 9,210 | — | ↗ |
| 2019-05-16 | Soni Manmeet Singh | Director | A-Award | A | Stock Option (right to buy) | 13,814 | 13.03 | 180.0K | 13,814 | — | ↗ |
| 2019-05-16 | Levinson Mitchell E. | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 13.03 | 195.5K | 15,000 | — | ↗ |
| 2019-05-16 | FOGARTY THOMAS J M D | Director | A-Award | A | Stock Option (right to buy) | 10,706 | 13.03 | 139.5K | 10,706 | — | ↗ |
| 2019-05-16 | DUGGAN ROBERT W | Director / 10% Owner | A-Award | A | Stock Option (right to buy) | 13,124 | 13.03 | 171.0K | 13,124 | — | ↗ |
| 2019-05-16 | Clark Kenneth A | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 13.03 | 195.5K | 15,000 | — | ↗ |
| 2019-03-18 | Levinson Mitchell E. | Director | — | I | Common Stock | 0 | 0.00 | — | 445 | — | ↗ |
| 2019-01-11 | Ebbers Ed | Officer | — | D | Common Stock | 0 | 0.00 | — | 40,376 | — | ↗ |
| 2019-01-07 | Zanganeh Maky | Director | A-Award | A | Stock Option (right to buy) | 2,364 | 13.22 | 31.3K | 2,364 | — | ↗ |
| 2019-01-07 | Soni Manmeet Singh | Director | A-Award | A | Stock Option (right to buy) | 4,066 | 13.22 | 53.8K | 4,066 | — | ↗ |
| 2019-01-07 | FOGARTY THOMAS J M D | Director | A-Award | A | Stock Option (right to buy) | 3,498 | 13.22 | 46.2K | 3,498 | — | ↗ |
| 2019-01-07 | DUGGAN ROBERT W | Director / 10% Owner | A-Award | A | Stock Option (right to buy) | 4,444 | 13.22 | 58.7K | 4,444 | — | ↗ |
| 2019-01-07 | Clark Kenneth A | Director | A-Award | A | Stock Option (right to buy) | 2,931 | 13.22 | 38.7K | 2,931 | — | ↗ |
| 2018-12-13 | DUGGAN ROBERT W | Director / 10% Owner | X-InTheMoney | A | Common Stock | 2,914,182 | 12.57 | 36.62M | 8,776,604 | — | ↗ |
| 2018-06-01 | UECKER DARRIN | Director / Officer | F-InKind | D | Common Stock | 7,168 | 16.10 | 115.4K | 153,981 | — | ↗ |
| 2018-05-23 | Zanganeh Maky | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 15.27 | 229.1K | 15,000 | — | ↗ |
| 2018-05-23 | Soni Manmeet Singh | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 15.27 | 229.1K | 15,000 | — | ↗ |
| 2018-05-23 | FOGARTY THOMAS J M D | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 15.27 | 229.1K | 15,000 | — | ↗ |
| 2018-05-23 | DUGGAN ROBERT W | Director / 10% Owner | A-Award | A | Stock Option (right to buy) | 15,000 | 15.27 | 229.1K | 15,000 | — | ↗ |
| 2018-05-23 | Clark Kenneth A | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 15.27 | 229.1K | 15,000 | — | ↗ |
| 2018-05-11 | DUGGAN ROBERT W | Director / 10% Owner | P-Purchase | A | Common Stock | 21,353 | 23.16 | 494.5K | 5,862,422 | — | ↗ |
| 2017-12-31 | Zanganeh Maky | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2017-12-13 | Zanganeh Maky | Director | P-Purchase | A | Common Stock | 1,100 | 23.98 | 26.4K | 95,574 | — | ↗ |
| 2017-12-13 | DUGGAN ROBERT W | Director / 10% Owner | P-Purchase | A | Common Stock | 20,556 | 22.44 | 461.3K | 5,841,069 | — | ↗ |
| 2017-12-12 | Zanganeh Maky | Director | P-Purchase | A | Common Stock | 1,000 | 23.98 | 24.0K | 94,474 | — | ↗ |
| 2017-12-11 | Zanganeh Maky | Director | P-Purchase | A | Common Stock | 3,000 | 22.76 | 68.3K | 93,474 | — | ↗ |
| 2017-11-02 | Zanganeh Maky | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 23.08 | 461.6K | 20,000 | — | ↗ |
| 2017-11-02 | Soni Manmeet Singh | Director | A-Award | A | Stock Option (right to buy) | 65,000 | 23.08 | 1.50M | 65,000 | — | ↗ |
| 2017-11-02 | FOGARTY THOMAS J M D | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2017-11-02 | DUGGAN ROBERT W | Director / 10% Owner | A-Award | A | Stock Option (right to buy) | 65,000 | 23.08 | 1.50M | 65,000 | — | ↗ |
| 2017-11-02 | Clark Kenneth A | Director | A-Award | A | Stock Option (right to buy) | 65,000 | 23.08 | 1.50M | 65,000 | — | ↗ |
| 2017-10-19 | DUGGAN ROBERT W | 10% Owner | P-Purchase | A | Common Stock | 22,901 | 22.79 | 521.9K | 5,820,513 | — | ↗ |
| 2017-09-24 | DUGGAN ROBERT W | 10% Owner | P-Purchase | A | Common Stock | 2,000,000 | 15.02 | 30.04M | 5,797,612 | — | ↗ |
| 2017-09-18 | Zanganeh Maky | Director | P-Purchase | A | Common Stock | 7,775 | 15.02 | 116.8K | 332,500 | — | ↗ |
| 2017-09-18 | DUGGAN ROBERT W | 10% Owner | P-Purchase | A | Common Stock | 23,703 | 15.12 | 358.3K | 3,790,115 | — | ↗ |
| 2017-09-15 | DUGGAN ROBERT W | 10% Owner | P-Purchase | A | Common Stock | 71,598 | 14.38 | 1.03M | 3,640,912 | — | ↗ |
| 2017-09-14 | Zanganeh Maky | Director | P-Purchase | A | Common Stock | 13,000 | 12.23 | 158.9K | 315,725 | — | ↗ |
| 2017-09-14 | Levinson Mitchell E. | Director | P-Purchase | A | Common Stock | 445 | 12.15 | 5.4K | 445 | — | ↗ |
| 2017-09-14 | DUGGAN ROBERT W | 10% Owner | P-Purchase | A | Common Stock | 50,300 | 11.66 | 586.6K | 3,437,994 | — | ↗ |
| 2017-08-03 | Zanganeh Maky | Director | P-Purchase | A | Common Stock | 5,000 | 23.00 | 115.0K | 90,474 | — | ↗ |
| 2017-08-03 | DUGGAN ROBERT W | 10% Owner | P-Purchase | A | Common Stock | 68,964 | 23.70 | 1.63M | 3,387,694 | — | ↗ |
| 2017-08-02 | Zanganeh Maky | Director | P-Purchase | A | Common Stock | 8,290 | 25.15 | 208.5K | 287,225 | — | ↗ |
| 2017-08-02 | DUGGAN ROBERT W | 10% Owner | P-Purchase | A | Common Stock | 38,290 | 25.12 | 961.9K | 3,318,730 | — | ↗ |
| 2017-08-01 | DUGGAN ROBERT W | 10% Owner | P-Purchase | A | Common Stock | 42,990 | 20.20 | 868.4K | 3,153,234 | — | ↗ |
| 2017-06-07 | UECKER DARRIN | Director / Officer | A-Award | A | Common Stock | 160,974 | 0.00 | — | 160,974 | — | ↗ |
| 2017-05-23 | DUGGAN ROBERT W | 10% Owner | P-Purchase | A | Common Stock | 2,000 | 28.07 | 56.1K | 3,110,244 | — | ↗ |
| 2017-05-22 | DUGGAN ROBERT W | 10% Owner | P-Purchase | A | Common Stock | 6,800 | 26.67 | 181.3K | 3,061,044 | — | ↗ |
| 2017-05-16 | Zanganeh Maky | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 27.14 | 407.1K | 15,000 | — | ↗ |
| 2017-05-16 | Thaure Thierry B. | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 27.14 | 407.1K | 15,000 | — | ↗ |
| 2017-05-16 | Levinson Mitchell E. | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 27.14 | 407.1K | 15,000 | — | ↗ |
| 2017-05-16 | LEVANDE ROBERT | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 27.14 | 407.1K | 15,000 | — | ↗ |
| 2017-05-16 | Greenberg Robert J. | Director | A-Award | A | Stock Option (right to buy) | 15,000 | 27.14 | 407.1K | 15,000 | — | ↗ |
| 2017-05-16 | Dow Brian B | Officer | A-Award | A | Stock Option (right to buy) | 95,000 | 27.14 | 2.58M | 95,000 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-9.7K
Shares Outstanding
68.23M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Burke T. Barrett Former Chief Executive Officer and Director | 327.3K | 108.5K | — | 8.00M | — | 1.4K | 8.44M | 94.82% | ↗ |
| 2 | 2024 | Kevin P. Danahy Chief Commercial Officer | 512.5K | 102.5K | — | — | — | 1.4K | 616.4K | 0.00% | ↗ |
| 3 | 2024 | Darrin R. Uecker Chief Technology Officer and Director | 512.5K | 102.5K | — | — | — | 1.4K | 616.4K | 0.00% | ↗ |
| 4 | 2023 | Kevin P. Danahy Chief Executive Officer | 433.3K | 400.0K | — | 5.03M | — | 1.4K | 5.86M | 85.77% | ↗ |
| 5 | 2023 | Kevin P. Danahy Chief Commercial Officer | 433.3K | 400.0K | — | 5.03M | — | 1.4K | 5.86M | 85.77% | ↗ |
| 6 | 2023 | Darrin R. Uecker Chief Technology Officer and Director | 433.3K | 400.0K | — | 4.56M | — | 1.4K | 5.39M | 84.51% | ↗ |
| 7 | 2023 | Mitchell E. Levinson Chief Strategy Officer | 369.6K | 213.6K | — | 1.11M | — | 1.4K | 1.69M | 65.50% | ↗ |
| 8 | 2022 | Kevin P. Danahy Chief Executive Officer | 350.0K | — | — | 1.91M | — | 1.2K | 2.26M | 84.48% | ↗ |
| 9 | 2022 | Darrin R. Uecker Chief Technology Officer and Director | 485.9K | — | — | — | — | 1.3K | 487.2K | 0.00% | ↗ |
| 10 | 2022 | Mitchell E. Levinson Chief Strategy Officer and Director | 360.0K | — | — | — | — | 1.3K | 361.3K | 0.00% | ↗ |
| 11 | 2022 | Mitchell E. Levinson Chief Strategy Officer | 360.0K | — | — | — | — | 1.3K | 361.3K | 0.00% | ↗ |
| 12 | 2021 | Darrin R. Uecker President, Chief Executive Officer and Director | 510.2K | — | — | 1.77M | — | 1.3K | 2.29M | 77.63% | ↗ |
| 13 | 2021 | Darrin R. Uecker Chief Technology Officer and Director | 510.2K | — | — | 1.77M | — | 1.3K | 2.29M | 77.63% | ↗ |
| 14 | 2021 | Mitchell E. Levinson Chief Strategy Officer and Director | 131.3K | — | — | 930.7K | — | 418.00 | 1.06M | 87.61% | ↗ |
| 15 | 2021 | Sandra Gardiner Executive Vice President, Finance and Administration and Chief Financial Officer | 416.7K | — | — | 583.4K | — | 1.3K | 1.00M | 58.26% | ↗ |
| 16 | 2020 | Darrin R. Uecker President, Chief Executive Officer and Director | 461.0K | 228.2K | — | 987.0K | — | 1.3K | 1.68M | 58.84% | ↗ |
| 17 | 2020 | Edward A. Ebbers Executive Vice President and General Manager, Dermatology | 320.8K | 102.9K | — | 987.0K | — | 1.3K | 1.41M | 69.90% | ↗ |
| 18 | 2020 | Sandra Gardiner Executive Vice President, Finance and Administration and Chief Financial Officer | 400.0K | 181.2K | — | 230.3K | — | 1.3K | 812.8K | 28.34% | ↗ |
| 19 | 2019 | Sandra Gardiner Executive Vice President, Finance and Administration and Chief Financial Officer | 50.0K | 40.0K | — | 2.01M | — | 257.00 | 2.10M | 95.70% | ↗ |
| 20 | 2019 | Darrin R. Uecker President, Chief Executive Officer and Director | 461.0K | 72.6K | — | — | — | 886.7K | 1.42M | 0.00% | ↗ |
| 21 | 2019 | Darrin R. Uecke r President, Chief Executive Officer and Director | 461.0K | 72.6K | — | — | — | 886.7K | 1.42M | 0.00% | ↗ |
| 22 | 2019 | Brian B. Dow Former Senior Vice President, Finance and Administration and Chief Financial Officer | 7.00 | — | — | — | — | 102.2K | 438.2K | 0.00% | ↗ |
| 23 | 2019 | Edward A. Ebbers Executive Vice President and General Manager, Dermatology | 300.0K | 55.8K | — | — | — | 64.1K | 419.9K | 0.00% | ↗ |
| 24 | 2018 | Darrin R. Uecker President, Chief Executive Officer and Director | 461.0K | 106.8K | — | — | — | 1.6K | 569.4K | 0.00% | ↗ |
| 25 | 2018 | Darrin R. Uecker, President, Chief Executive Officer and Director | 461.0K | 106.8K | — | — | — | — | 569.4K | 0.00% | ↗ |
| 26 | 2018 | Darrin R. Uecke r President, Chief Executive Officer and Director | 461.0K | 4.00 | — | — | — | 1.6K | 569.4K | 0.00% | ↗ |
| 27 | 2018 | Brian B. Dow, Senior Vice President, Finance and Administration and Chief Financial Officer | 336.0K | 43.9K | — | — | — | — | 381.4K | 0.00% | ↗ |
| 28 | 2018 | Brian B. Dow Former Senior Vice President, Finance and Administration and Chief Financial Officer | 336.0K | 9.00 | — | — | — | 1.5K | 381.4K | 0.00% | ↗ |
| 29 | 2018 | Edward A. Ebbers, Executive Vice President and General Manager, Dermatology | 252.1K | 49.5K | — | — | — | — | 303.1K | 0.00% | ↗ |
| 30 | 2018 | Edward A. Ebbers Executive Vice President and General Manager, Dermatology | 252.1K | 49.5K | — | — | — | 1.5K | 303.1K | 0.00% | ↗ |
| 31 | 2017 | Darrin R. Uecke r President, Chief Executive Officer and Director | 330.0K | 5.00 | 4.99M | 8.22M | — | 888.00 | 13.63M | 96.94% | ↗ |
| 32 | 2017 | Darrin R. Uecker, President, Chief Executive Officer and Director | 330.0K | 85.9K | 4.99M | 8.22M | — | — | 13.63M | 96.94% | ↗ |
| 33 | 2017 | Brian B. Dow Former Senior Vice President, Finance and Administration and Chief Financial Officer | 260.0K | 10.00 | — | 1.79M | — | 888.00 | 2.10M | 85.28% | ↗ |
| 34 | 2017 | Brian B. Dow, Senior Vice President, Finance and Administration and Chief Financial Officer | 260.0K | 48.4K | — | 1.79M | — | — | 2.10M | 85.28% | ↗ |
| 35 | 2016 | Darrin R. Uecker, President, Chief Executive Officer and Director | 300.0K | 93.6K | — | — | — | — | 393.6K | 0.00% | ↗ |
| 36 | 2016 | Brian B. Dow, Senior Vice President, Finance and Administration and Chief Financial Officer | 250.0K | 35.8K | — | — | — | — | 285.8K | 0.00% | ↗ |
| 37 | 2015 | Darrin R. Uecker, President, Chief Executive Officer and Director | 72.1K | 10.0K | — | 839.0K | — | — | 921.1K | 91.08% | ↗ |
| 38 | 2015 | Brian B. Dow, Senior Vice President, Finance and Administration and Chief Financial Officer | 20.8K | — | — | 420.6K | — | — | 441.4K | 95.28% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Darrin R. Uecker | Chief Technology Officer & Director | 616.4K | male |
| Kevin Danahy | Chief Commercial Officer | 616.4K | male |
| Mitchell E. Levinson | Chief Strategy Officer | 584.6K | male |
| Paul Arthur LaViolette | President, Chief Executive Officer & Co-Chairman of the Board | 52.9K | male |
| Gansevoort Dunnington | Chief Medical Officer | — | — |
| Jon Skinner | Chief Financial Officer | — | male |
| Kenneth Stratton | General Counsel & Corporate Secretary | — | male |
| Steven T. Weber | Vice President of Accounting, Principal Accounting Officer & Global Corporate Controller | — | male |
| Liane Teplitsky | Chief Operating Officer | — | female |
| Niv Ad | Chief Science Officer of Cardiac Surgery | — | — |
| Patty Perla | Vice President of Human Resources | — | female |
| David Kenigsberg | Chief Medical Officer | — | — |
ESG Rating
ESG Score History MEDICAL - INSTRUMENTS & SUPPLIES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for PLSE
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
